RxDoctor Payments Data

Katherine Brady, DO

Obstetrics & Gynecology · Maplewood, MNNPI 1033524160

Payments from drug & device makers

$497in general payments, 2019–2025

Across 27 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$89
  • Bayer$45
  • AbbVie$39
  • Astellas Pharma US Inc$37
  • Coloplast$35
  • Johnson & Johnson$33
  • plus $219 from 12 others

What the payments were for

  • Food & beverage$48497%
  • Education$133%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.1$89
Bayer3$45
AbbVie3$39
Astellas Pharma US Inc2$37
Coloplast2$35
Johnson & Johnson2$33
Monaghan Medical Corporation1$32
Coopersurgical, Inc.1$27
Exeltis, USA Inc.2$25
Northgate Technologies, Inc.1$24
Boston Scientific1$22
Medtronic1$19
Axonics, Inc.1$17
Roche Diagnostics Corporation1$14
AMAG Pharmaceuticals, Inc.1$13
Therapeuticsmd, Inc.1$12
Organon1$12
Unified Women's Healthcare, LP2$0

How this compares

$497 in reported general payments places this provider in the 70th percentile of 615 obstetrics & gynecology providers in Minnesota.

See all obstetrics & gynecology providers in Minnesota

Medicare billing

Part B allowed, 2024
$7,984
Medicare patients
43
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol67$3,517

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Maplewood

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →